Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice – the ECSTATIC study: a cluster randomised non-inferiority trial

BACKGROUND: The use of cardiovascular medication for the primary prevention of cardiovascular disease (CVD) is potentially inappropriate when potential risks outweigh the potential benefits. It is unknown whether deprescribing preventive cardiovascular medication in patients without a strict indicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Luymes, Clare H., Poortvliet, Rosalinde K. E., van Geloven, Nan, de Waal, Margot W. M., Drewes, Yvonne M., Blom, Jeanet W., Smidt, Nynke, Assendelft, Willem J. J., van den Hout, Wilbert B., de Ruijter, Wouter, Numans, Mattijs E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763574/
https://www.ncbi.nlm.nih.gov/pubmed/29321031
http://dx.doi.org/10.1186/s12916-017-0988-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763574/
https://www.ncbi.nlm.nih.gov/pubmed/29321031
http://dx.doi.org/10.1186/s12916-017-0988-0

Ejemplares similares